Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20063429HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020738HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063343HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20019412HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020739HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20014999HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063872HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020740HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20020741HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TVIS20063341HPVENSG00000120217.14protein_codingCD274YesNo29126Q9NZQ7
TCGA Plot Options
Drug Information
GeneCD274
DrugBank IDDB00313
Drug NameValproic acid
Target IDBE0003441
UniProt IDQ9NZQ7
Regulation Typedownregulator
PubMed IDs28812434
CitationsBooth L, Roberts JL, Poklepovic A, Dent P: [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells. Cancer Biol Ther. 2017 Sep 2;18(9):705-714. doi: 10.1080/15384047.2017.1362511.
GroupsApproved; Investigational
Direct ClassificationMethyl-branched fatty acids
SMILESCCCC(CCC)C(O)=O
PathwaysValproic Acid Metabolism Pathway
PharmGKBPA451846
ChEMBLCHEMBL109